Background Multivessel disease (MVD) occurs in ~40% of STEMI. Management is controversial. PRAMI and CVLPRIT showed improved clinical outcomes with complete versus infarct-related artery (IRA)-only revascularisation at primary percutaneous coronary intervention (PPCI). However, non-IRA PCI may cause additional infarcts. We aimed to determine whether in-hospital complete revascularisation was associated with increased myocardial injury versus an IRA-only strategy.
Methods Multicentre, prospective, randomised, blinded endpoint trial. STEMI patients with MVD and <12 hr symptoms were randomised to IRA-only or complete in-hospital PCI. 1.5T CMR was performed acutely (median 3 days post-PPCI) and with adenosine stress at 9 months. The primary CMR endpoint was acute infarct size on late gadolinium imaging. Myocardial salvage index (MSI) was the proportion of non-infarcted area-at-risk. n = 100 per group gave 80% power to detect ±4% infarct size. The primary clinical outcome was 12 month combined MACE (death, repeat revascularisation, heart failure, MI).
Validation studies optimised infarct, area-at-risk and strain quantification. Full-width half-maximum infarct quantification was more accurate, reproducible and correlated strongest with ejection fraction (LVEF) and infarct characteristics. Otsu’s Automated Thresholding most accurately and reproducibly assessed area-at-risk. Compared with tagging, Feature Tracking strain measurement was more robust, quicker, had better interobserver variability and correlated stronger with infarct, area-at-risk and MSI.
Results (summarised in Table 1) 203 patients (98 complete revascularisation, 105 IRA-only) completed acute CMR. The groups were well matched. There was no difference in infarct size, MSI, LVEF, circumferential strain or ischaemic burden between groups. Complete revascularisation patients had increased non-IRA MI at acute CMR (Figure 1). 12 month MACE was reduced in complete revascularisation patients (8.2% vs. 17.1%, p = 0.055, hazard ratio 0.43).
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.